Bridget Everett isn’t quite sure how she could ever top “Somebody Somewhere.” The show ended its three-season run at the end of 2024 with a moving gathering of the show’s characters and a ...

The event featured some of the buzziest names of this TV awards cycle, from Bridget Everett, the star and executive producer of HBO’s critically acclaimed “Somebody Somewhere,” to Abby ...

sought to measure weight gain after stopping the use of weight loss medication, or GLP-1 receptor agonists. Researchers determined that ceasing older weight loss medications resulted in a return ...

Share on Pinterest Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly. Shelby Knowles/Bloomberg/Getty Images Zepbound outperformed ...

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer. By Rebecca Robbins Novo Nordisk will replace its ...

After fans took notice of her new appearance, Trainor addressed her significant weight loss on Instagram, attributing her transformation to "huge lifestyle changes" such as using the weight-loss ...

Share on Pinterest New research explores the potential of protein bars enriched with collagen as a weight loss aid. Jeff Wasserman/Stocksy A study conducted by Spanish researchers analyzed how ...

Weight-loss medications known as glucagon-like peptide-1 (GLP-1) agonists, which have gained popularity for treating type 2 diabetes and obesity, have been shown to have the surprising secondary ...

Shweta Tiwari's post-pregnancy weight loss journey inspires many, as she shed over 10 kilos in her 40s through mindful changes. Shweta Tiwari didn’t just lose weight. She gained more energy ...

Weight loss drugs are popular for helping patients quickly shed pounds Drugs like Ozempic are controversial for their side effects Side effects of some drugs can range from nausea to kidney ...

Perspective from Sangeeta Kashyap, MD Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, according to findings from the ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published, examining their ability to reduce weight and waist circumference.